Research lead by Northwestern University in Chicago shows that people with chronic kidney disease and type 2 diabetes are at significantly increased risk of earlier heart disease. The research, which will be presented at the American Heart Association’s Scientific Sessions 2024 later this week by Vaishnavi Krishnan, a researcher at…

Regular mobile phone use is linked to increased cardiovascular disease risk, especially in current smokers and individuals with diabetes, according to a new large-scale cohort study that used UK Biobank data. This association, the researchers say, was partly attributed to poor sleep, psychological distress, and neuroticism. The team is led…

The V142I transthyretin variant, present in three to four percent of self-identified Black individuals in the U.S., increases the risk for both heart failure and death and contributes to significant decreases in longevity, according to work by researchers at Brigham and Women’s Hospital and Duke University.  Their study looked at…

Results from a large study carried out in Sweden show that long-term use of attention-deficit/hyperactivity disorder (ADHD) medication can increase cardiovascular disease (CVD) risk. Zheng Chang, a group leader at the Karolinska Institutet in Stockholm, and colleagues found that for every year of ADHD medication use CVD risk increased by…

The Million Hearts Model, a cardiovascular disease event prevention program created by the U.S. Centers for Medicare & Medicaid Services (CMS), significantly reduced the risk of heart attacks, strokes and related deaths. As reported in JAMA, the model, which paid healthcare providers to carry out cardiovascular disease (CVD) risk assessments,…

A new review published in The Lancet Neurology by researchers at Mass General Brigham presents findings indicating that cardiovascular disease risk may be increased by traumatic brain injury (TBI). The review presented evidence of the long-term associations between TBI and cardiovascular disease noting that post-injury comorbidities, as well as neuroinflammation,…

An analysis of more than 460 million lipid test results from 17 countries on five continents has provided evidence that variation in cardiovascular disease risk is based on influences from where a person lives and their sex. The study, performed by researchers at Johns Hopkins University and the Quest Diagnostics-led…

A study by UK Biobank has found that cancer survivors may be at long-term heightened risk of cardiovascular disease, irrespective of traditional underlying risk factors, with those who have survived blood cancer and breast cancer, most vulnerable. While most of the evidence to date suggests that the highest risk of…

A study led by Yale University School of Medicine shows a significant link between prenatal depression and subsequent cardiovascular disease. The study was reported in the Journal of the American Heart Association and showed women who were depressed during pregnancy had a 32–83% increased risk of developing some form of…

Sequencing leader Illumina announced it has entered a partnership with Henry Ford Health in Detroit to assess the impact and utility of comprehensive genomic profiling (CGP) for patients with cardiovascular disease. The program, dubbed CardioSeq, will comprise the implementation of clinical studies using next-generation sequencing technology, including whole-genome sequencing, to…

The Genotype and Phenotype Database of Monogenic Cardiovascular Disease, or CardioGen, has been established by China’s BGI Genomics, together with the National Center for Cardiovascular Diseases, Fuwai Hospital, and the State Key Laboratory of Cardiovascular Diseases. CardioGen collects and integrates information about gene-causing diseases and clinical phenotype information of patients found in…

Researchers in Canada have helped explain how the PCSK9 protein degrades low-density lipoprotein (LDL) receptors. Their findings add key insight to the understanding of how atherosclerosis develops. The richest cholesterol particles in the bloodstream, LDLs are strongly linked to cardiovascular disease. But PCSK9 also plays a role in cancer. The…

Researchers at Brigham and Womens Hospital in Boston, MA have succeeded in markedly reducing the levels of bad cholesterol in patients suffering from cardiovascular disease in a clinical trial using the investigational drug Olpasiran. Cardiovascular disease is the leading cause of death for people of most racial and ethnic groups in the United…

Research led by St George’s University of London shows that retinal imaging can be a good predictor of cardiovascular health when combined with artificial intelligence (AI) analysis tools. As reported in the British Journal of Ophthalmology, the team created an AI-based tool using information from more than 65,000 individuals to…

Researchers have for some time linked saturated fat, dietary cholesterol, sodium, nitrites, and even high-temperature cooking, with increased risk of developing atherosclerotic cardiovascular disease (ASCVD). Yet, to date, direct evidence of the mechanisms of these factors has not be clear. Now, a new approach to this question by researchers at…